Cosmos Pharmaceuticals
Middletown, US · Founded 2017 · Delaware corporation · 24 employees on LinkedIn · 1 known investors
FortisKap makes a fingerprint-secured connected cap for standard prescription vials that logs who opens a medication, when, and how many pills remain, producing time-stamped adherence data. It is aimed at patients, families, and clinicians as well as care programs to track medication access, misuse, and diversion.
Founders & leadership
JW
Joseph W. WhiteExecutive
AM
Alexander M. ColtonExecutive
PM
Philip McBrideinEngineering Lead / CosmosRx Software
M
MelissainCommercialization Executive
A
AlexinTechnical Development Lead
NM
Nick MorseinClinical Lead
J
JoshinGrowth Strategy Lead
TK
Tanveer KanalainFinance & Market Strategy Lead
Board
BE
Bart EdmundsBoard director
CC
Christian ColtonBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 3 rounds · 2020–2025
▶$750KraisedOct 2025 · 14 investors · Other Health CareRule 506(b)
▶$750KraisedOct 2025 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph W. WhiteExecutive Officer, Director
- Alexander M. ColtonExecutive Officer, Director
- Philip McBrideExecutive Officer
- Bart EdmundsDirector
- Christian ColtonDirector
- Offering amount
- $1.3M
- Amount sold
- $750K
- Proceeds to insiders
- $550K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$175KraisedJun 2022 · 7 investors · Other Health CareRule 506(b)
▶$175KraisedJun 2022 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alexander M. ColtonExecutive Officer, Director
- Joseph W. WhiteExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $175K
- Minimum investment
- $10K
- First sale
- May 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$225KraisedFeb 2021 · 7 investors · Other Health CareRule 506(b)
▶$225KraisedFeb 2021 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph W. WhiteExecutive Officer, Director
- Alexander M. ColtonExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $225K
- Minimum investment
- $10K
- Proceeds to insiders
- $10K
- First sale
- Dec 2020
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cosmos Pharmaceuticals do?
- FortisKap makes a fingerprint-secured connected cap for standard prescription vials that logs who opens a medication, when, and how many pills remain, producing time-stamped adherence data. It is aimed at patients, families, and clinicians as well as care programs to track medication access, misuse, and diversion.
- Who are Cosmos Pharmaceuticals's investors?
- Cosmos Pharmaceuticals's investors include The Innovation Space.
- How much funding has Cosmos Pharmaceuticals raised?
- Cosmos Pharmaceuticals has disclosed $1.1M raised across 3 rounds.
- Where is Cosmos Pharmaceuticals headquartered?
- Cosmos Pharmaceuticals is headquartered in Middletown, US.